A Double Blind, Randomized, Placebo Controlled, Parallel Group Dose-Range Exploration Study of Sativex in Relieving Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy.

Trial Profile

A Double Blind, Randomized, Placebo Controlled, Parallel Group Dose-Range Exploration Study of Sativex in Relieving Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Nabiximols (Primary) ; Opioid analgesics
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Acronyms SPRAY
  • Sponsors GW Pharmaceuticals
  • Most Recent Events

    • 05 Apr 2012 Results published in the Journal of Pain.
    • 05 Apr 2012 Primary endpoint 'Response-rate' has not been met.
    • 05 Apr 2012 Primary endpoint 'Numerical-Rating-Scale' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top